Acute illnesses affecting the respiratory tract are common and form a significant component of the work of Sport and Exercise Medicine (SEM) clinicians. Acute respiratory illness (ARill) can broadly be classified as non-infective ARill and acute respiratory infections (ARinf). The aim of this consensus is to provide the SEM clinician with an overview and practical clinical approach to ARinf in athletes. The International Olympic Committee (IOC) Medical and Scientific Commission appointed an international consensus group to review ARill (non-infective ARill and ARinf) in athletes. Six subgroups of the IOC Consensus group were initially established to review the following key areas of ARill in athletes: (1) epidemiology/risk factors for ARill, (2) ARinf, (3) non-infective ARill including ARill due to environmental exposure, (4) acute asthma and related conditions, (5) effects of ARill on exercise/sports performance, medical complications/return-to-sport and (6) acute nasal/vocal cord dysfunction presenting as ARill. Several systematic and narrative reviews were conducted by IOC consensus subgroups, and these then formed the basis of sections in the consensus documents. Drafting and internal review of sections were allocated to € core' members of the consensus group, and an advanced draft of the consensus document was discussed during a meeting of the main consensus core group in Lausanne, Switzerland on 11 to 12 October 2021. Final edits were completed after the meeting. This consensus document (part 1) focusses on ARinf, which accounts for the majority of ARill in athletes. The first section of this consensus proposes a set of definitions and classifications of ARinf in athletes to standardise future data collection and reporting. The remainder of the consensus paper examines a wide range of clinical considerations related to ARinf in athletes: epidemiology, risk factors, pathology/pathophysiology, clinical presentation and diagnosis, management, prevention, medical considerations, risks of infection during exercise, effects of infection on exercise/sports performance and return-to-sport guidelines.

International olympic committee (ioc) consensus statement on acute respiratory illness in athletes part 1: acute respiratory infections / Schwellnus, Martin; Adami, Paolo Emilio; Bougault, Valerie; Budgett, Richard; Clemm, Hege Havstad; Derman, Wayne; Erdener, Uğur; Fitch, Ken; Hull, James H; Mcintosh, Cameron; Meyer, Tim; Pedersen, Lars; Pyne, David B; Reier-Nilsen, Tonje; Schobersberger, Wolfgang; Schumacher, Yorck Olaf; Sewry, Nicola; Soligard, Torbjørn; Valtonen, Maarit; Webborn, Nick; Engebretsen, Lars. - In: BRITISH JOURNAL OF SPORTS MEDICINE. - ISSN 0306-3674. - (2022), pp. 1-23. [10.1136/bjsports-2022-105759]

International olympic committee (ioc) consensus statement on acute respiratory illness in athletes part 1: acute respiratory infections

Adami, Paolo Emilio
Secondo
Membro del Collaboration Group
;
2022

Abstract

Acute illnesses affecting the respiratory tract are common and form a significant component of the work of Sport and Exercise Medicine (SEM) clinicians. Acute respiratory illness (ARill) can broadly be classified as non-infective ARill and acute respiratory infections (ARinf). The aim of this consensus is to provide the SEM clinician with an overview and practical clinical approach to ARinf in athletes. The International Olympic Committee (IOC) Medical and Scientific Commission appointed an international consensus group to review ARill (non-infective ARill and ARinf) in athletes. Six subgroups of the IOC Consensus group were initially established to review the following key areas of ARill in athletes: (1) epidemiology/risk factors for ARill, (2) ARinf, (3) non-infective ARill including ARill due to environmental exposure, (4) acute asthma and related conditions, (5) effects of ARill on exercise/sports performance, medical complications/return-to-sport and (6) acute nasal/vocal cord dysfunction presenting as ARill. Several systematic and narrative reviews were conducted by IOC consensus subgroups, and these then formed the basis of sections in the consensus documents. Drafting and internal review of sections were allocated to € core' members of the consensus group, and an advanced draft of the consensus document was discussed during a meeting of the main consensus core group in Lausanne, Switzerland on 11 to 12 October 2021. Final edits were completed after the meeting. This consensus document (part 1) focusses on ARinf, which accounts for the majority of ARill in athletes. The first section of this consensus proposes a set of definitions and classifications of ARinf in athletes to standardise future data collection and reporting. The remainder of the consensus paper examines a wide range of clinical considerations related to ARinf in athletes: epidemiology, risk factors, pathology/pathophysiology, clinical presentation and diagnosis, management, prevention, medical considerations, risks of infection during exercise, effects of infection on exercise/sports performance and return-to-sport guidelines.
2022
consensus; ioc; respiratory system
01 Pubblicazione su rivista::01a Articolo in rivista
International olympic committee (ioc) consensus statement on acute respiratory illness in athletes part 1: acute respiratory infections / Schwellnus, Martin; Adami, Paolo Emilio; Bougault, Valerie; Budgett, Richard; Clemm, Hege Havstad; Derman, Wayne; Erdener, Uğur; Fitch, Ken; Hull, James H; Mcintosh, Cameron; Meyer, Tim; Pedersen, Lars; Pyne, David B; Reier-Nilsen, Tonje; Schobersberger, Wolfgang; Schumacher, Yorck Olaf; Sewry, Nicola; Soligard, Torbjørn; Valtonen, Maarit; Webborn, Nick; Engebretsen, Lars. - In: BRITISH JOURNAL OF SPORTS MEDICINE. - ISSN 0306-3674. - (2022), pp. 1-23. [10.1136/bjsports-2022-105759]
File allegati a questo prodotto
File Dimensione Formato  
Schwellnus_International-Olympic_2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.73 MB
Formato Adobe PDF
1.73 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1743748
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 26
social impact